Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286078 · ClinicalTrials.gov registry record · NA
Treatment for Migraines With an Implantable Device
A NA study of Migraine, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
- 15
- Study locations
NCT00286078 is a NA study of Migraine that has completed, run by Boston Scientific Corporation. The registered enrollment target is 179 participants, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (50% lower). The trial reports 15 study locations across 14 states.
The verdict
NCT00286078, a NA study of Migraine, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
Conditions Studied
Interventions
- DEVICE Precision
Study Locations (15)
Illinois
- Rush Pain Center - Chicago
- Diamond Headache Clinic - Chicago
Colorado
- Mile High Research Center - Denver
Connecticut
- The New England Center for Headache - Stamford
Georgia
- Walton Rehabilitation Hospital - Augusta
Massachusetts
- New England Regional Headache Center - Worcester
Missouri
- Headache Care Center - Springfield
Nevada
- Headache Specialists - Las Vegas
New York
- Albert Einstein College of Medicine - Montefiore Headache Unit - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2006-02 |
| Est. Completion | 2018-11-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00286078
The ClinicalTrials.gov registry entry for NCT00286078 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (50% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Precision is the first listed.
NCT00286078 reports 15 study locations spanning 14 distinct geographic areas - top geographies include Illinois, Colorado, Connecticut.
Frequently Asked Questions
What is clinical trial NCT00286078 about?
NCT00286078 is a clinical study titled "Treatment for Migraines With an Implantable Device". The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
What is the current status of trial NCT00286078?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2006-02. Estimated completion is 2018-11-07.
What conditions does trial NCT00286078 study?
This clinical trial studies the following conditions: Migraine.
What interventions are being tested in trial NCT00286078?
The interventions under investigation include: Precision (DEVICE).
Who is sponsoring clinical trial NCT00286078?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00286078 being conducted?
This trial has 15 study locations across Colorado, Connecticut, Georgia, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.